Trial intelligence / Profile preview

Getong Tongluo Capsule in Ischemic Stroke

NCT07690020Not yet recruiting

Sponsor
Nanfang Hospital, Southern Medical University
Start
Aug 2026
Primary completion
Jul 2029
01

Overview

Randomised, double-blind trial of getong tongluo in ischemic stroke (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoints: Modified Rankin Scale at 6 months and Adverse Events at 6 months. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

getong tongluo
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT07690020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07690020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call